semaglutide removed from shortage list and Tirzepatide off FDA list: What does this mean for weight loss drug access? GLP-1 Shortage = Over -

Patients should feel comfortable discussing any changes they notice after starting semaglutide, including night sweats

All but 1 omnivorous subject completed all 3 visits

Conceptually, a metabolic reprogramming agent potentiates the efficacy of an antibiotic in the same manner as an adjuvant potentiates the immunogenicity of an antigen

Phase 2 obesity trial (NEJM 2023) adverse events by maintenance dose (where a dose had two escalation arms, the range across both arms is shown): Phase 2 type 2 diabetes trial (Lancet 2023): mild-to-moderate gastrointestinal adverse events (nausea, diarrhea, vomiting, constipation) were reported in 35% of retatrutide participants ranging from 13% at 0.5 mg to 50% in the 8 mg fast-escalation group compared with 13% on placebo and 35% on dulaglutide 1.5 mg